Upregulation of renal sodium transporters in D5 dopamine receptor-deficient mice

Hypertension

Volumn 55, Issue 6, 2010, Pages 1431-1437

  Wang, Xiaoyan ^a   Luo, Yingjin ^a   Escano, Crisanto S ^a   Yang, Zhiwei ^b   Asico, Laureano ^a   Li, Hewang ^a   Jones, John E ^a   Armando, Ines ^a   Lu, Quansheng ^a   Sibley, David R ^c   Eisner, Gilbert M ^a   Jose, Pedro A ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF LABORATORY ANIMAL SCIENCE   (China)

^c NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

AT1R blockade; Dopamine; Dopamine receptor; Hypertension; Knockout mouse; Sodium excretion; Sodium transporters

Indexed keywords

ALDOSTERONE; ANGIOTENSIN 1 RECEPTOR; CHLORIDE ION; CREATININE; DOPAMINE 5 RECEPTOR; EPITHELIAL SODIUM CHANNEL; LOSARTAN; POTASSIUM ION; RENIN; SODIUM CHLORIDE COTRANSPORTER; SODIUM ION; SODIUM PHOSPHATE COTRANSPORTER 2; SODIUM POTASSIUM CHLORIDE COTRANSPORTER; SODIUM PROTON EXCHANGE PROTEIN 3;

ALDOSTERONE URINE LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; GENE DISRUPTION; GENE EXPRESSION REGULATION; KIDNEY PROXIMAL TUBULE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RECEPTOR BLOCKING; RECEPTOR UPREGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RENOVASCULAR HYPERTENSION; SALT LOADING; SODIUM INTAKE; SODIUM RETENTION; SODIUM TRANSPORT; SODIUM URINE LEVEL;

ANALYSIS OF VARIANCE; ANIMALS; DIET, SODIUM-RESTRICTED; DISEASE MODELS, ANIMAL; HYPERTENSION; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; KIDNEY CORTEX; KIDNEY MEDULLA; LOSARTAN; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PROBABILITY; RANDOM ALLOCATION; RECEPTORS, DOPAMINE D5; SODIUM CHANNELS; SODIUM CHLORIDE SYMPORTERS; SODIUM-POTASSIUM-CHLORIDE SYMPORTERS; UP-REGULATION;

EID: 77952953846     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.148643     Document Type: Article

References (38)

1. Jose PA, Eisner GM, Felder RA. Renal dopamine receptors in health and hypertension. Pharmacol Ther. 1998;80:149-182.
2. Hussain T, Lokhandwala MF. Renal dopamine receptor function in hypertension. Hypertension. 1998;32:187-197.
3. Wang X, Villar VA, Armando I, Eisner GM, Felder RA, Jose PA. Dopamine, kidney, and hypertension: studies in dopamine receptor knockout mice. Pediatr Nephrol. 2008;23:2131-2146.
4. Grandy DK, Allen LJ, Zhang Y, Magenis RE, Civelli O. Chromosomal localization of three human D5 dopamine receptor genes. Genomics. 1992;13:968-973.
5. Allayee H, de Bruin TW, Dominguez KM, Cheng LS, Ipp E, Cantor RM, Krass KL, Keulen ET, Aouizerat BE, Lusis AJ, Rotter JI. Genome scan for blood pressure in Dutch dyslipidemic families reveals linkage to a locus on chromosome 4p. Hypertension. 2001;38:773-778.
6. Casari G, Barlassina C, Cusi D, Zagato L, Muirhead R, Righetti M, Nembri P, Amar K, Gatti M, Macciardi F, Binelli G, Bianchi G. Association of the a-adducin locus with essential hypertension. Hypertension. 1995;25:320-326.
7. Cohn DH, Shohat T, Yahav M, Ilan T, Rechavi G, King L, Shohat M. A locus for an autosomal dominant form of progressive renal failure and hypertension at chromosome 1q21. Am J Hum Genet. 2000;67:647-651.
8. Cooper RS, Luke A, Zhu X, Kan D, Adeyemo A, Rotimi C, Bouzekri N, Ward R, Rorimi C. Genome scan among Nigerians linking blood pressure to chromosomes 2, 3, and 19. Hypertension. 2002;40:629-633.
9. Cravchik A, Gejman PV. Functional analysis of the human D5 dopamine receptor missense and nonsense variants: differences in dopamine binding affinities. Pharmacogenetics. 1999;9:199-206. (Pubitemid 29359002)
10. Hollon TR, Bek MJ, Lachowicz JE, Ariano MA, Mezey E, Ram-achandran R, Wersinger SR, Soares-da-Silva P, Liu ZF, Grinberg A, Drago J, Young WS III, Westphal H, Jose PA, Sibley DR. Mice lacking D5 dopamine receptors have increased sympathetic tone and are hypertensive. J Neurosci. 2002;22:10801-10810.
11. Yang Z, Asico LD, Yu P, Wang Z, Jones JE, Escano CS, Wang X, Quinn MT, Sibley DR, Romero GG, Felder RA, Jose PA. D5 dopamine receptor regulation of reactive oxygen species production, NADPH oxidase, and blood pressure. Am J Physiol Regul Integr Comp Physiol. 2006;290: R96-R104.
12. 13-protein subunit linkage of D5 dopamine receptors in the nephron. Hypertension. 2003;41:604-610.
13. Zeng C, Yang Z, Wang Z, Jones J, Wang X, Altea J, Mangrum AJ, Hopfer U, Sibley DR, Eisner GM, Felder RA, Jose PA. Interaction of angiotensin II type 1 and D5 dopamine receptors in renal proximal tubule cells. Hypertension. 2005;45:804-810.
14. Sugiyama F, Churchill GA, Higgins DC, Johns C, Makaritsis KP, Gavras H, Paigen B. Concordance of murine quantitative trait loci for salt-induced hypertension with rat and human loci. Genomics. 2001;71: 70-77.
15. Bek MJ, Wang X, Asico LD, Jones JE, Zheng S, Li X, Eisner GM, Grandy DK, Carey RM, Soares-da-Silva P, Jose PA. Angiotensin-II type 1 receptor-mediated hypertension in D4 dopamine receptor-deficient mice. Hypertension. 2006;47:288-295.
16. Fernandez-Llama P, Andrews P, Ecelbarger CA, Nielsen S, Knepper MA. Concentrating defect in experimental nephrotic syndrome: altered expression of aquaporins and thick ascending limb Na+ transporters. Kidney Int. 1998;54:170-179.
17. Kim GH, Martin SW, Fernandez-Llama P, Masilamani S, Packer RK, Knepper M. A. Long-term regulation of sodium-dependent cotransporters and ENaC in rat kidney: response to altered acid-base intake. Am J Physiol Renal Physiol. 2000;279:F459-F467.
18. Tiwari S, Nordquist L, Halagappa VK, Ecelbarger CA. Trafficking of ENaC subunits in response to acute insulin in mouse kidney. Am J Physiol Renal Physiol. 2007;293:F178-F185.
19. Kim GH, Ecelbarger CA, Mitchell C, Packer RK, Wade JB, Knepper MA. Vasopressin increases Na-K-2Cl cotransporter expression in thick ascending limb of Henle's loop. Am J Physiol. 1999;276:F96-F103.
20. Kim GH, Masilamani S, Turner R, Mitchell C, Wade JB, Knepper MA. The thiazide-sensitive Na-Cl cotransporter is an aldosterone-induced protein. Proc Natl Acad Sci USA. 1998;95:14552-14557.
21. Masilamani S, Kim GH, Mitchell C, Wade JB, Knepper MA. Aldoste-rone-mediated regulation of ENaC a,/3, and y subunit proteins in rat kidney. J Clin Invest. 1999;104:R19-R23.
22. + exchanger interactions in the kidney in hypertension. Hypertension. 2000;36:395-399.
23. Li XX, Bek M, Asico LD, Yang Z, Grandy DK, Goldstein DS, Rubinstein M, Eisner GM, Jose PA. Adrenergic and endothelin B receptor-dependent hypertension in dopamine receptor type-2 knockout mice. Hypertension. 2001;38:303-308.
24. 2-like dopamine receptor interaction in the spontaneously hypertensive rat. Am J Physiol Regul Integr Comp Physiol. 2001;281:R1071-R1078.
25. Wang XY, Masilamani S, Nielsen J, Kwon TH, Brooks HL, Nielsen S, Knepper MA. The renal thiazide-sensitive Na-Cl cotransporter as mediator of the aldosterone-escape phenomenon. J Clin Invest. 2001;108: 215-222.
26. Li H, Armando I, Yu P, Escano C, Mueller SC, Asico L, Pascua A, Lu Q, Wang X, Villar VA, Jones JE, Wang Z, Periasamy A, Lau YS, Soares-da-Silva P, Creswell K, Guillemette G, Sibley DR, Eisner G, Gildea JJ, Felder RA, Jose PA. Dopamine 5 receptor mediates Ang II type 1 receptor degradation via an ubiquitin-proteasome pathway in mice and human cells. J Clin Invest. 2008;118:2180-2189.
27. Yang LE, Sandberg MB, Can AD, Pihakaski-Maunsbach K, McDonough AA. Effects of dietary salt on renal Na+ transporter subcellular distribution, abundance, and phosphorylation status. Am J Physiol Renal Physiol. 2008;295:F1003-F1016.
28. Oliverio MI, Best CF, Smithies O, Coffman TM. Regulation of sodium balance and blood pressure by the AT1A receptor for angiotensin II. Hypertension. 2000;35:550-554.
29. Mattson DL, Krauski KR. Chronic sodium balance and blood pressure response to captopril in conscious mice. Hypertension. 1998;32:923-928.
30. Ge Y, Bagnall A, Stricklett PK, Webb D, Kotelevtsev Y, Kohan DE. Combined knockout of collecting duct endothelin A and B receptors causes hypertension and sodium retention. Am J Physiol Renal Physiol. 2008;295:F1635-F1640.
31. Crowley SD, Gurley SB, Oliverio MI, Pazmino AK, Griffiths R, Flannery PJ, Spurney RF, Kim HS, Smithies O, Le TH, Coffman TM. Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system. J Clin Invest. 2005;115:1092-1099.
32. Granger JP, Alexander BT, Llinas M. Mechanisms of pressure natriuresis. Curr Hypertens Rep. 2002;4:152-159.
33. Frindt G, Palmer LG. Surface expression of sodium channels and transporters in rat kidney: effects of dietary sodium. Am J Physiol Renal Physiol. 2009;297:F1249-F1255.
34. + transporter and channel abundances in angiotensin II type 1a receptor knockout mice. Hypertension. 2002;39: 470-473.
35. Beutler KT, Masilamani S, Turban S, Nielsen J, Brooks HL, Ageloff S, Fenton RA, Packer RK, Knepper MA. Long-term regulation of ENaC expression in kidney by angiotensin II. Hypertension. 2003;41: 1143-1150.
36. Charpentier S, Jarvie KR, Severynse DM, Caron MG, Tiberi M. Silencing of the constitutive activity of the dopamine D1B receptor. Reciprocal mutations between D1 receptor subtypes delineate residues underlying activation properties. J Biol Chem. 1996;271:28071-28076.
37. Strachan FE, Spratt JC, Wilkinson IB, Johnston NR, Gray GA, Webb DJ. Systemic blockade of the endothelin-B receptor increases peripheral vascular resistance in healthy men. Hypertension. 1999;33:581-585.
38. Allcock GH, Warner TD, Vane JR. Roles of endothelin receptors in the regional and systemic vascular responses to ET-1 in the anaesthetized ganglion-blocked rat: use of selective antagonists. Br J Pharmacol. 1995; 116:2482-2486.